Danish CDMO founded in 1956 specializing in process development and API manufacturing for biotech and pharma companies taking new chemical entities (NCEs) from discovery to commercialization. Operates a multi-purpose GMP pilot plant with glass/glass-lined reactors (40-280L) including cryogenic capability (-80 degrees C). Services include process development, analytical development, reference samples, supply of API for toxicology and clinical studies, API release, ICH stability studies, and GMP documentation. QC lab equipped with HPLC (DAD/CAD), IC, GC-MS, and LC-MS/MS (QTOF).
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.